{"symbol":"MRK","provider":"yahoo-finance","fetchedAt":"2025-12-22T21:56:06.821Z","asOfDate":"2025-12-22","articles":[{"id":"65a995e2-731e-3bd8-ac46-a5c62b2ff7d7","title":"SCHD vs. NOBL: Different Paths to Dividend Stability","url":"https://finance.yahoo.com/m/65a995e2-731e-3bd8-ac46-a5c62b2ff7d7/schd-vs.-nobl%3A-different.html","publisher":"Motley Fool","publishedAt":"2025-12-22T21:31:52.000Z","relatedTickers":["SCHD"],"mainIdea":"SCHD vs. NOBL: Different Paths to Dividend Stability","summary":"Motley Fool: SCHD vs. NOBL: Different Paths to Dividend Stability. Both ETFs target dividend paying stocks, but their rules determine whether investors receive higher income or stricter dividend consistency Related tickers mentioned: SCHD."},{"id":"13190dd5-50f6-360e-8931-02493ad33b77","title":"“Merck (MRK) is an Inexpensive Stock,” Says Jim Cramer","url":"https://finance.yahoo.com/news/merck-mrk-inexpensive-stock-says-172937950.html","publisher":"Insider Monkey","publishedAt":"2025-12-22T17:29:37.000Z","relatedTickers":[],"mainIdea":"“Merck (MRK) is an Inexpensive Stock,” Says Jim Cramer","summary":"Insider Monkey: “Merck (MRK) is an Inexpensive Stock,” Says Jim Cramer. We recently published 8 Stocks on Jim Cramer’s Radar. Merck & Co., Inc. (NYSE:MRK) is one of the stocks on Jim Cramer’s radars. Pharma giant Merck & Co., Inc. (NYSE:MRK)’s shares are up by 1.9% year-to-date on the back of a strong run since early November. Before the run started, the stock was down 16.8% […]"},{"id":"619e667d-d82c-327c-b226-63865170214e","title":"Analyst Report: Merck & Co., Inc.","url":"https://finance.yahoo.com/m/619e667d-d82c-327c-b226-63865170214e/analyst-report%3A-merck-%26-co.%2C.html","publisher":"Morningstar Research","publishedAt":"2025-12-22T16:38:21.000Z","relatedTickers":[],"mainIdea":"Analyst Report: Merck & Co., Inc.","summary":"Morningstar Research: Analyst Report: Merck & Co., Inc.. Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm"}]}
